Temtokibart Biosimilar - Research Grade

Human

IL22RA1ï؟½

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q8N6P7;Q80XZ4

Blue ice

The IL-22 receptor alpha-1 chain (IL22RA1) transduces IL-22 signals that regulate epithelial barrier function and inflammation, drawing interest in dermatology and mucosal research. Offered here is a research-grade, unconjugated analog of temtokibart, a recombinant monoclonal antibody against IL22RA1, for research use only. It is produced to in vivo standards in a low-endotoxin format and supplied in scalable milligram to gram quantities for bulk and high-throughput laboratories. The antibody supports receptor-blockade functional assays, in vitro IL-22-signaling screens, and in vivo models of inflammatory skin and barrier disease. Its reproducible formulation and scalable volumes support standardized results in bulk research.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks